Y-mAbs Therapeutics Inc.
YMAB
|
|
| |
|
| Trading Volume | 3,374 |
|
|
18.69 - 4.86 |
| Market Cap Full | $ 611.6M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 4.2% | 139% | 2.7% | -26.7% |
| Q2 | - | -6.8% | 35.5% | 27.4% |
| Q3 | - | 13.9% | -19.7% | -4.7% |
| Q4 | - | -49.7% | 27.5% | -66.2% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 87.5 | 30.6 | -2.4 | -7.1 | - | - | - | 13.9 | - | - | - | -34.4 |
| 2023 | |||||||||||
| -8 | -15.4 | 31.8 | 19.6 | 35.7 | -16.5 | -10.3 | -16.8 | 7.5 | -2 | 16.3 | 9.8 |
| 2022 | |||||||||||
| -39 | -7.9 | 30.4 | -21.2 | 32.5 | 22 | 0.7 | 5.5 | -10.3 | -75 | 23.8 | 9.2 |
| 2021 | |||||||||||
| -15.2 | -17.8 | -12.4 | -0.6 | 22 | -7.8 | -3.6 | -5.5 | -7.3 | -12.1 | -32 | -5.1 |
| 2020 | |||||||||||
| 6.7 | -17.2 | -5.8 | 28.7 | 13.7 | 13.2 | -18.7 | 22 | -10.5 | 11.3 | 19 | -2.7 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.2 | -0.6 | 0.8 | -0.7 |
| Q2 | -0.1 | -0.9 | -0.5 | -1 |
| Q3 | -0.2 | -0.6 | -0.7 | -0.8 |
| Q4 | 0 | 0 | -0.8 | -0.5 |
| A | -0.47 | -2.2 | -1.3 | -3 |